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Dementia Research Group, Clinical Neurosciences, University of Bristol, Bristol, United Kingdom
Pericytes are vascular mural cells that contract and relax in response to vasoactive
stimuli to regulate neurovascular coupling and cerebral blood flow. Pericytes are
damaged and degenerate in Alzheimer’s disease (AD). We previously showed that the
level of the regulatory vasoconstrictor, endothelin-1 (EDN1), is elevated in AD cerebral
cortex and upregulated by amyloid-beta (Aβ). We have used electrical impedance
analysis to monitor the contractile and proliferative response of cultured human fetal
and adult brain-derived pericytes to EDN1 in real-time. EDN1 caused transient, dose-
dependent contraction of fetal and adult brain pericytes that was mediated by EDN1
type A receptors and increased the subsequent proliferation of fetal but not adult cells.
The contractile responses to EDN1 were weaker in the adult pericytes. The EDN1-
mediated contractile response of fetal pericytes was unchanged after exposure to
Aβ1−40 or Aβ1−42 (0.1–10 µM) for 1 h but both contraction and subsequent relaxation
were significantly impaired upon exposure to Aβ for 24 h. These data suggest that
chronic exposure to Aβ interferes with EDN1-mediated pericyte contractility, potentially
contributing to neurovascular uncoupling and reduced cerebral blood flow in AD.
Keywords: Aβ peptide, Alzheimer’s disease, electrical impedance, endothelin-1, pericyte
INTRODUCTION
Pericytes are vascular mural cells that are particularly abundant within the brain. They are expressed
within the capillary network but also reside on pre- and post-capillary vessels. Pericytes are critical
components of the neurovascular unit and dynamically regulate cerebral blood flow (CBF) in
response to local metabolic demand (Joyce et al., 1985; Neuhaus et al., 2017; Nortley et al., 2019). In
stroke, pericytes die in rigor, clamping shut capillary lumina, contributing to ischemic injury (Hall
et al., 2014; Heyba et al., 2019). Recent studies indicate that pericytes are damaged and degenerate
in Alzheimer’s disease (AD) and vascular dementia (VaD) (Sagare et al., 2013; Kisler et al., 2017;
Ding et al., 2020). This is thought to play a major role in blood-brain barrier (BBB) breakdown and
cerebral hypoperfusion, and to affect clearance of Aβ in AD (Daneman et al., 2010).
Brain ischemia has long been recognized as the principal pathological process in VaD but
recent studies have shown that cerebral hypoperfusion and BBB leakiness are early and substantial
contributors to disease progression and cognitive decline in AD (Ding et al., 2020). We previously
showed that the enzymes responsible for synthesis of the vasoconstrictor peptide endothelin-1
(EDN1) were upregulated in AD (Palmer et al., 2009, 2013) and associated with elevated EDN1
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level in the cerebral cortex. The level of EDN1 correlated strongly
with biochemical evidence of cerebral hypoperfusion in AD and
with the level of Aβ, which we found to increase the production
of EDN1 by neurons and endothelial cells in vitro (Palmer
et al., 2012). EDN1 induces contraction of smooth muscle cells,
causing constriction of penetrating arteries and arterioles and
reducing blood flow in the cerebral cortex and deep within
the brain (Wynne et al., 2009). A recent study confirmed that
capillaries were constricted in proximity to Aβ plaques in human
biopsy brain tissue and that mechanistically, reactive oxygen
species in response to oligomeric Aβ mediated EDN1-induced
pericyte contraction and consequent narrowing of capillaries in
brain cortical slices, and was likely to contribute to cerebral
hypoperfusion in AD (Nortley et al., 2019).
In vitro studies of pericyte function have been performed
with bovine retinal pericytes (Yamagishi et al., 1993) using
semi-quantitative methods, such as the “wrinkling assay”
[pericyte contraction causes folds when the cells are grown
on a silicone membrane (Durham et al., 2014)], and with
brain-derived human pericytes isolated from fetal brain tissue
(ScienCell, United States) (Persidsky et al., 2016; Neuhaus
et al., 2017). The fetal cells express pericyte markers such
as platelet-derived growth factor receptor-β (PDGFRβ) and
chondroitin sulfate proteoglycan-4 (NG2) and are negative for
endothelial markers and non-vascular markers including GFAP
and IBA1 (Hall et al., 2014). The cells respond to vasoactive
metabolites and contract and migrate in culture (Neuhaus et al.,
2017; Nortley et al., 2019; Kemp Scott et al., 2020). They
have been shown to express α-smooth muscle actin (α-SMA)
(Nehls and Drenckhahn, 1991).
Fetal pericytes are responsive to multiple vasoactive peptides
in the brain, and contract in response to EDN1 as previously
shown using an electrical impedance assay (Neuhaus et al., 2017).
It remains unclear whether the pathophysiological responses of
fetal brain pericytes reflect those in the adult brain. EDN1 also
evokes pericyte-mediated constriction of capillaries in human
and rat cortical slices in response to oligomeric Aβ (Nortley
et al., 2019). In the present study, we have assessed EDN1-
mediated contraction of fetal and adult brain-derived pericytes
by use of an electrical impedance assay and investigated whether




Human brain vascular pericytes of fetal origin (fHBVP; ScienCell,
United States) and human brain vascular pericytes of adult
origin (aHBVP; Cell Systems, United States) were grown in
pericyte medium (ScienCell, United States) at 37◦C in 5% CO2.
All experiments were performed using cells at passages of <8.
Cells were cultured in poly-L-lysine-coated flasks (10 mg/mL)
until 80% confluent and then sub-cultured following the
manufacturer’s protocol. All work was performed in a Class II
microbiological safety cabinet (Holten, United Kingdom) under
sterile conditions.
Immunofluorescent Labeling of Pericytes
Immunofluorescence was used to assess the expression and
distribution of cell-specific markers. Cells were cultured on poly-
L-lysine coated coverslips and left to grow for 24 h at 37◦C
in a 5% CO2 incubator. The medium was aspirated, and cells
were washed gently three times with PBS before being fixed in
4% paraformaldehyde (PFA; Sigma-Aldrich, United States) for
10 min at 37◦C in a 5% CO2 incubator. PFA was removed
and cells were washed three more times in PBS and left in
PBS at 4◦C until immunolabelled. At this point, PBS was
removed, cold methanol added, and the cells incubated at
−20◦C for 10 min, washed with PBS 3 times for 1 min
each and then blocked with 5% donkey serum (Sigma-Aldrich,
United States) for 30 min at room temperature (RT). The cells
were incubated with primary antibody overnight at 4◦C: α-SMA
(1:100, Abcam United Kingdom, rabbit polyclonal), PDGFRβ
(1:500, R&D Systems United States, biotinylated goat polyclonal),
EDNRA (1:500, Abcam United Kingdom, rabbit polyclonal), and
EDNRB (1:1000, Abcam United Kingdom, rabbit polyclonal). The
cells were washed again in PBS three times for 1 min each
followed by addition of a donkey anti-rabbit IgG Alexa Fluor
488 (Invitrogen, United Kingdom) secondary antibody (1:500) for
α-SMA and streptavidin Alexa Fluor 488 conjugate (Invitrogen,
United Kingdom) for PDGFRβ for 1 h at RT in the dark.
Samples were washed in PBS three times for 1 min each and
coverslips were placed onto glass microscope slides and mounted
using Vectashield mounting medium with DAPI (Vector Labs,
United States). Slides were stored at 4◦C in the dark before being
imaged by confocal microscopy (Nikon Eclipse 80i).
EDN1-Mediated Contraction of Pericytes
Assessed Using an Electrical Impedance
Assay (xCELLigence)
Pericytes (fHBVP and aHBVP) were seeded at 5000 cells/well
onto pre-coated poly-L-lysine impedance plates (E-plate VIEW R©
96 or E Plate insert 16 R©, ACEA Biosciences, United States)
and allowed to adhere for 1 h at RT within the hood and
then overnight in the incubator at 37◦C, 5% CO2. Cells were
then starved in serum-free medium for 2 h. EDN1 (Abcam,
United Kingdom) was added in situ and the cell index (see below)
was measured using either the xCELLigence R© RTCA S16 or SP96-
well plates (ACEA Biosciences, United States) maintained at 37◦C
in a 5% CO2 incubator. The cell index was recorded in real-
time throughout the duration of the experiment. Addition of
serum-free medium was used as a vehicle control. The relative
impedance is presented as a “cell index” (an arbitrary value
derived from the impedance software) which reflects the contact
surface area between cells and the culture dish and the resistance
to electrical current (see Supplementary Figure 1); the average
normalized cell index for a particular well is generated by
normalizing the raw cell index data with reference to the mean
index across duplicate vehicle control wells. Upon addition of
EDN1, parameters for the xCELLigence software were set to
record in 5 s intervals for a total duration of 2 h (contraction-
relaxation phase) and then 1 h intervals for a further 48 h
(proliferation phase). Data analyses were performed using RTCA
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Data Analysis Software 1.0 (ACEABiosciences, United States). The
change in slope (1/h) of the cell index curve, to reflect the rate
of responses, was calculated using the built-in function of the
data analysis software. Measurements were recorded in duplicate
wells for each condition; “n” refers to the number of independent
experimental repeats.
To assess the effect of receptor blockers on EDN1-mediated
contraction, BQ123 (Tocris, United Kingdom) and BQ788 (Sigma-
Aldrich, United States) were added in serum-free medium, 1 h
before the addition of EDN1.
To assess the effect of Aβ1−40 (rPeptide, United States) and
Aβ1−42 (rPeptide, United States) on EDN1-mediated contraction,
freshly solubilized Aβ peptides prepared in 35% acetonitrile and
diluted in serum-free medium were added either 1 or 24 h prior
to the addition of EDN1.
Statistical Software
All statistical analyses were performed using GraphPad Prism
8.1.2 software package. Unpaired two-tailed t-tests or ANOVA
with Dunnett’s multiple comparisons post hoc tests were selected
and used for comparisons between groups as appropriate.
P-values of<0.05 were considered statistically significant.
RESULTS
Pericytes Isolated From Fetal and Adult
Human Brain Express Pericyte Markers
fHBVP (ScienCell, United States) and aHBVP (Cell-Systems,
United States) expressed the canonical pericyte marker PDGFRβ
(Figures 1A,B). Pericytes expressed α-SMA (Figures 1C,D) and
both endothelin-1 type A (EDNRA) (Figures 1E,F) and type B
(EDNRB) receptors (Figures 1G,H).
EDN1-Induced Contraction and
Proliferation of Fetal Brain-Derived
Pericytes
Electrical impedance assays (xCELLigence) were used to assess
pericyte contraction, relaxation, and proliferation in response to
EDN1, as previously reported (Neuhaus et al., 2017). Immediately
after addition of EDN1, pericyte contraction caused a rapid
decrease in cell index (relative impedance), followed by a
relaxation phase (∼10 min) – a classic G-protein coupled
receptor response – and subsequent proliferation, leading to a
progressive rise in cell index over 48–72 h (Figure 2).
The rate of contraction of fHBVPs increased with the
concentration of EDN1 (1 ρM–1 µM) as illustrated in Figure 2A.
The initial rapid decrease in cell index over control values (cells
in pericyte medium only) was significant after exposure to 1 nM
(p = 0.0039), 0.01 µM (p = 0.0003), 0.1 µM (p < 0.0001), or
1 µM (p < 0.0001) EDN1 (n = 12) (Figure 2B). Contraction was
followed by an increase in cell index (i.e., relaxation) as illustrated
in Figure 2C. The rate of increase was related to the previous rate
of decrease and was significantly higher in cells that had been
exposed to 0.1 nM (p = 0.0085), 1 nM (p < 0.0001), 0.01 µM
(p < 0.0001), 0.1 µM (p < 0.0001), or 1 µM (p < 0.0001) EDN1
(n = 12) (Figure 2D).
To monitor the effects of EDN1 on proliferation, the
impedance was monitored for a further 48–72 h (Figure 2E),
during which impedance rose reflecting an increase in the
number of cells covering the plate. The rate of increase
was calculated and indicated that proliferation of fHBVP was
significantly greater than in untreated control cells when exposed
to 0.1 nM (p = 0.0290), 1 nM (p = 0.0008), 0.01 µM
(p = 0.0038), 0.1 µM (p = 0.0041), or 1 µM (p = 0.0004)
EDN1 (n = 12) (Figure 2F). We similarly showed proliferation of
fHBVPs in response to EDN1 using a standardized BRDU assay
(Supplementary Figure 2).
Pretreatment with BQ123, an EDNRA antagonist, inhibited
EDN1-mediated pericyte contraction in a dose-dependent
manner (Figure 3A). A significant reduction in the rate of
contraction induced by EDN1 (100 nM) was observed in cells
pre-treated with BQ123 at 1 µM (p = 0.0158) or 10 µM
(p = 0.0001) (n = 7) (Figure 3B). Pre-incubation with BQ788,
an EDNRB receptor antagonist, did not significantly alter EDN1-
induced pericyte contraction (n = 7) (Figures 3C,D).
Adult Brain-Derived Pericytes Contract
in Response to EDN1 via EDNRA but Do
Not Proliferate
EDN1 induced contraction of aHBVP. The rate of initial decline
of cell index (i.e., contraction) was dose-related (1 ρM–1 µM), as
illustrated in Figure 4A. The rate of contraction was significantly
higher in adult cells treated with 0.1 µM (p = 0.0008) or 1 µM
(p < 0.0001) EDN1 than in untreated cells (n = 4) (Figure 4B).
The initial contraction was followed by a slower increase in cell
index (i.e., relaxation), as shown in Figure 4C; the increase in cell
index was most rapid after 0.1 µM EDN1 exposure (p = 0.0159)
(n = 4) (Figure 4D).
Impedance was monitored for a further 48 h to assess the effect
of EDN1 on adult pericyte proliferation. The cell index increased
slowly (Figure 4E) and was not affected by exposure to EDN1
(n = 4) (Figure 4F).
Pre-treatment with BQ123 inhibited EDN1-mediated
contraction of aHBVP (Figure 5A). A significant reduction
in the rate of contraction induced by EDN1 (100 nM) was
seen in pericytes pre-treated with 0.1 µM (p = 0.0154), 1 µM
(p = 0.0241), or 10 µM (p = 0.0016) BQ123 compared to cells
treated with EDN1 alone (n = 7) (Figure 5B). Pre-treatment
with BQ788 did not significantly influence EDN1-induced adult
pericyte contraction (Figures 5C,D).
EDN1-Induced Contractile Response of
Fetal Pericytes Was Impaired by
Exposure to Aβ Peptides
To investigate the acute effects of Aβ on EDN1-induced
contraction of fHBVP we pre-incubated cells with Aβ1−40 or
Aβ1−42 (10–0.1 µM) 1 h before the addition of EDN1 (100 nM).
Neither contraction nor relaxation was significantly altered with
exposure to Aβ1−40 or Aβ1−42 (Figures 6A–H).
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FIGURE 1 | Fetal human brain-derived vascular pericytes (fHBVP) and adult human brain-derived vascular pericytes (aHBVP), expressed PDGFRβ (A,B), α-SMA
(C,D) and both endothelin-1 type A (EDNRA) (E,F) and type B (EDNRB) receptors (G,H). All counterstained with a nuclear marker (DAPI – blue). Magnification 40×.
Scale bar represents 50 µM.
We next determined if longer exposure to Aβ peptides for
24 h impacted fHBVP contractility. Pre-treatment with 1 µM
Aβ1−40 for 24 h significantly impaired EDN1-induced pericyte
contraction (p = 0.0249) (Figures 7A,B). The subsequent increase
in cell index (reflecting relaxation) was also significantly slower
in cells treated with 1 µM Aβ1−40 (p = 0.0409) (Figures 7C,D).
The contractile response to EDN1 tended also to be lower after
pre-treatment with Aβ1−42 but the difference was not statistically
significant (n = 6) (Figures 7E–H).
Exposure to Aβ1−40 and Aβ1−42 for 24 h at concentrations
above 1 µM caused pericyte death, indicated by the incorporation
of ethidium-1 dye. Pericyte death was minimal at Aβ1−40 and
Aβ1−42 levels below 1 µM (Supplementary Figure 3).
It was not possible to assess the effects of prolonged exposure
of aHBVP to EDN1 because of deteriorating viability and
responsiveness of the adult cells after 24 h exposure to Aβ1−40
or Aβ1−42.
DISCUSSION
In this study, we have used electrical impedance assays
(xCELLigence) to characterize the contractile and proliferative
responses of fHBVP and aHBVP to EDN1. EDN1-induced
contraction of fHBVP and aHBVP was mediated specifically by
activation of EDNRA. The contractile responses were stronger in
the fetal than adult cells, and the former proliferated after EDN1-
induced contraction whereas the latter did not. Exposure to
Aβ1−40 for 24 h significantly abrogated the contractile response
to EDN1 in fHBVP, and subsequent relaxation. In the absence of
EDN1, neither Aβ1−40 nor Aβ1−42 induced cell contraction.
Pericytes respond to vasoactive stimuli; ATP (Hørlyck et al.,
2021) and EDN1 (Chakravarthy et al., 1992) induce pericyte
contraction whereas adenosine and nitric oxide cause pericyte
relaxation (Neuhaus et al., 2017). In human and rat cortical
slices, noradrenaline constricts, and glutamate dilates capillaries
in proximity to pericyte cell bodies (Peppiatt et al., 2006;
Hall et al., 2014; Nortley et al., 2019). EDN1 was previously
reported to cause pericyte contraction of bovine retinal pericytes
(Chakravarthy et al., 1992), associated with the release of cytosolic
Ca2+ and reorganization of actin filaments (Dehouck et al., 1997).
More recently, EDN1 was shown to induce strong pericyte-
mediated contraction reducing the lumina of capillaries in rat
cortical slices – an effect mediated by the EDNRA receptor
(Neuhaus et al., 2017; Nortley et al., 2019). Neuhaus et al.
(2017) demonstrated the utility of xCELLigence to first measure
contraction, relaxation and proliferation of human fetal brain-
derived pericytes in response to EDN1 and various vascular
stimuli. We have confirmed that EDN1 induces contraction of
fHBVP, across a similar dose range to that previously reported
(1 nM–1 µM), reflecting the normal concentration of EDN1
in human plasma (3.55 ± 1.78 ρg/ml) (Kostov et al., 2016).
The contractile response was dose-dependent and was typical
of a classical G-protein coupled response (Billington and Penn,
2003). We have extended the previous findings and demonstrated
that both fHBVP and aHBVP are responsive to EDN1, and that
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FIGURE 2 | (A) Representative electrical impedance measurements of the contractile response of fetal human brain vascular pericytes (fHBVP) to EDN1. (B) The
rate of contraction was significantly increased by addition of 1 nM (p = 0.0039, Dunnett’s test), 0.01 µM (p = 0.0003), 0.1 µM (p < 0.0001) or 1 µM (p < 0.0001)
EDN1 (n = 12). (C) Representative electrical impedance measurements of the relaxation response of fHBVP following contraction. (D) The increased rate of
contraction was followed by more rapid relaxation in cells treated with 0.1 nM (p = 0.0085), 1 nM (p < 0.0001), 0.01 µM (p < 0.0001), 0.1 µM (p < 0.0001) or 1 µM
(p < 0.0001) (n = 12). (E) Representative electrical impedance measurements of the proliferative response of the fHBVP after EDN1. (F) Proliferation was significantly
increased after the addition of 0.1 nM (p = 0.0290), 1 nM (p = 0.0008), 0.01 µM (p = 0.0038), 0.1 µM (p = 0.0041), or 1 µM (p = 0.0004) EDN1 (n = 12). The bars
represent the mean values and SEM. Arrows indicate time of EDN1 addition. The timeframe referred to in each graph is indicated by the red bracket.
the contraction is mediated through activation of the EDNRA
receptor. Exposure to EDN1 alone does not cause pericyte
toxicity, with longer exposure causing cell proliferation between
48 and 72 h (Neuhaus et al., 2017).
Fetal pericytes were more responsive to EDN1. The minimum
concentration of EDN1 needed to elicit contraction in aHBVP
was 0.1 µM–100 times greater than needed for contraction of
fHBVP. aHBVP also took longer to relax following contraction,
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FIGURE 3 | (A) Representative electrical impedance measurements of the contractile response of fetal human brain vascular pericytes (fHBVP) to EDN1 in the
presence of BQ123, an EDNRA antagonist. (B) The rate of contraction was significantly reduced in cells to which 1 µM (p = 0.0158) or 10 µM (p = 0.0001) BQ123
had been added (n = 7). (C) Representative electrical impedance measurements of the contractile response of fHBVP in the presence of BQ788, an EDNRB
antagonist. (D) There was no significant difference in the rate of contraction between BQ788-treated and untreated cells (n = 7). The timeframe referred to in each
graph is indicated by the red bracket. Arrows indicate the timepoint of EDN1 addition. The bars represent the mean values and SEM.
as demonstrated by the slower increase in cell index following
contraction compared to that for fHBVP. Impaired relaxation
of aHBVP could potentially affect neurovascular coupling and
contribute to cerebral hypoperfusion in normal aging. Unlike
fHBVP, which proliferated in response to EDN1 as reported
previously (Neuhaus et al., 2017), aHBVP did not. Whether
this reflects a genuine physiological difference between pericytes
obtained from fetal and adult brains or is specific to this
commercial source of pericytes (Cell-Systems), remains to be
determined. Further studies to characterize the morphology and
physiology of fetal and adult brain-derived pericytes and their
anatomical subtypes should provide important insights into age-
and disease-related pericyte dysfunction.
Soluble Aβ peptides, consisting of monomeric and oligomeric
species cause a slow constriction of brain capillaries, mediated
by pericyte contraction, reducing the diameter of the vessel
lumen by up to 25% in human and rat cortical sections (Nortley
et al., 2019). Transgenic rats treated with Aβ1−40 in the lateral
ventricles showed an increase in EDNRA expression in the
cerebral cortex, hippocampus, and brain stem (Briyal et al., 2011).
We therefore wondered whether pre-exposure to Aβ had an
impact on EDN1-induced contraction of fHBVP and aHBVP
in vitro.
Short-term exposure had no effect. However, 24 h exposure
of fHBVP to Aβ1−40, at concentrations reported in the human
brain (∼6 nM) (Nortley et al., 2019), significantly altered the
contractile response of pericytes to EDN1. Higher concentrations
of Aβ (in the micromolar range) impaired the contractile
responses of pericytes but this may have been partly because
of cell toxicity. Previous studies found that exposure to 5–
25 µM Aβ1−40 over 3–7 days caused degenerative changes
(Verbeek et al., 1997; Sagare et al., 2013) whereas 1.4 µM
for 3 h did not cause pericyte death in rat cortical slices
(Nortley et al., 2019). We have not found evidence of pericyte
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FIGURE 4 | (A) Representative electrical impedance measurements of the contractile response of adult human brain vascular pericytes (aHBVP) to EDN1. (B) The
rate of contraction was significantly higher after adding 0.1 µM (p = 0.0008) or 1 µM (p < 0.0001) EDN1 (n = 4). (C) Representative electrical impedance
measurements of the relaxation response of aHBVP following contraction. (D) The rate of subsequent relaxation was significantly higher in cells to which 0.1 µM
(p = 0.0159) EDN1 had been added (n = 4). (E) Representative electrical impedance measurements of the proliferative response of the aHBVP to EDN1. (F) No
significant difference in rate of proliferation between EDN1-treated and control cells was found (n = 4). The timeframe referred to in each graph is indicated by the red
bracket. Arrows indicate the timepoint of EDN1 addition. The bars represent the mean values and SEM.
degeneration at concentrations of Aβ1−40or Aβ1−42 below
1 µM over a 24 h period. Relaxation of fHBVP was also
impaired after exposure to Aβ1−40. The deleterious impact
of Aβ on pericyte responsiveness – slowing and reducing
the contractile responses as well as subsequent relaxation –
is likely to interfere with the rapid adaptation of capillary
blood flow to changes in neuronal metabolic demand, and
suggests a mechanism whereby elevated Aβ may contribute to
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FIGURE 5 | (A) Representative electrical impedance measurements of the contractile response of adult human brain vascular pericytes (aHBVP) to EDN1 in the
presence of BQ123, an EDNRA antagonist. (B) The rate of contraction was significantly reduced in cells to which 0.1 µM (p = 0.0241), 1 µM (p = 0.0154), or 10 µM
(p = 0.0016) BQ123 had been added (n = 7). (C) Representative electrical impedance measurements of the contractile response of aHBVP in the presence of
BQ788, an EDNRB antagonist. (D) There was no significant difference in the rate of contraction between BQ788-treated and untreated cells (n = 7). Data shows
mean rate of contraction ± SEM. The timeframe referred to in each graph is indicated by the red bracket. Arrows indicate the timepoint of EDN1 addition. The bars
represent the mean values and SEM.
neurovascular uncoupling and cerebral hypoperfusion in AD. It
remains to be determined the extent to which the aggregation
states of Aβ (monomeric, oligomeric, and fibrillar), influences
pericyte contractile function and the impact of Aβ on pericyte
responses to vasodilators such as NO, adenosine and PGE2, also
merits further study.
Limitations of this study include the reliance on single
sources and batches of human fetal and adult pericytes. Pericytes
are likely to show heterogeneity of responsiveness in vivo,
because of multiple genetic and epigenetic factors. Although
the fetal pericytes have been used in numerous studies and
express canonical pericyte receptors including PDGFRβ, NG2,
and desmin (Neuhaus et al., 2017), we are still unsure of the
precise CNS source of these cells and our observations need
to be confirmed by study of pericyte function in vivo. Recent
transcriptomic studies, such as Vanlandewijck et al. (2018)
suggest that these cells may represent vascular fibroblast-like
cells rather than pericytes (personal communication) especially
after long term culture. This needs further analysis, although
we would note that our studies were all on cells that had
been passaged fewer than 8 times. We have used a reductionist
approach to examine pericytes in isolation whereas in vivo,
the actions of EDN1 may potentially be modulated locally by
neurons, endothelial cells, astrocytes, and microglia. Lastly, we
have relied on electrical impedance measurements as proxy
indicators of contraction and proliferation. EDN1 was previously
shown to mediate proliferation in a study that used both
xCELLigence and traditional trypan-blue cell counting (Neuhaus
et al., 2017), and we have used a BRDU assay to confirm
pericyte proliferation in response to EDN1 (Supplementary
Figure 2). Other methods, such as measuring the relative
change in cell area by confocal microscopy (Hørlyck et al.,
2021), are likely to be useful in future in vivo studies to
validate our findings.
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FIGURE 6 | (A) Representative electrical impedance measurements of the contractile response of fetal human brain vascular pericytes (fHBVP) to EDN1 (100 nM)
after 1 h incubation with Aβ1−40 (n = 1). (B) There was no significant difference between the rate of contraction of EDN1-treated cells following pre-exposure to
Aβ1−40 (n = 7). (C) Representative electrical impedance measurements of the relaxation response of fHBVP following contraction (n = 1). (D) There was also no
significant difference between the rate of subsequent relaxation EDN1-treated cells following pre-exposure to Aβ1−40 (n = 7). (E) Representative electrical impedance
measurements of the contractile response of these fHBVP to EDN1 (100 nM) after 1 h treatment with Aβ1−42 (n = 1). (F) The differences in the rate of contraction
between EDN1-treated cells following pre-exposure to Aβ1−42 were not statistically significant (n = 7). (G) Representative electrical impedance measurements of the
relaxation response of fHBVP following contraction (n = 1). (H) There was also no significant difference in rate of subsequent relaxation (n = 7). The timeframe
referred to in each graph is indicated by the red bracket. Arrows indicate the timepoint of EDN1 addition. The bars represent the mean values and SEM.
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FIGURE 7 | (A) Representative electrical impedance measurements of the contractile response of fetal human brain vascular pericytes (fHBVP) to EDN1 (100 nM)
after 24 h incubation with Aβ1−40 (n = 1). (B) There was a significant difference between the rate of contraction of untreated cells and those exposed to 1 µm
(p = 0.0249) Aβ1−40 (n = 9). (C) Representative electrical impedance measurements of the relaxation response of fHBVP following contraction (n = 1). (D) There was
also a significant difference between the rate of subsequent relaxation in untreated of cells and those exposed to 1 µm (p = 0.0409) Aβ1−40 (n = 9).
(E) Representative electrical impedance measurements of the contractile response of these fHBVP to EDN1 (100 nM) after 24 h treatment with Aβ1−42 (n = 1).
(F) The differences in the rate of contraction between EDN1-treated cells following pre-exposure to Aβ1−42 were not statistically significant (n = 9).
(G) Representative electrical impedance measurements of the relaxation response of fHBVP following contraction (n = 1). (H) There was also no significant difference
in rate of subsequent relaxation (n = 9). The timeframe referred to in each graph is indicated by the red bracket. Arrows indicate the timepoint of EDN1 addition. The
bars represent the mean values and SEM.
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In conclusion, we have shown that fetal and adult brain-
derived pericytes contract in response to activation of EDNRA
by EDN1. Adult pericytes were less sensitive than fetal pericytes
to EDN1 and remained contracted for longer. The contractile
response of fetal pericytes was impaired after chronic exposure
to Aβ. These differences may be relevant to disease pathogenesis
and should be considered in the design of future studies.
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Supplementary Figure 2 | Fetal human brain-derived vascular pericytes
(fHBVPs) were seeded in a 96-well plate at 5,000 cells per well and left to settle
overnight. Pericytes were incubated with purified recombinant EDN1 (diluted in
serum free medium) for 72 h (n = 1). A BRDU incorporation assay (Abcam,
United Kingdom) was used according to the manufacturer’s instructions to assess
pericyte proliferation.
Supplementary Figure 3 | (A) Fetal human brain-derived vascular pericytes
(fHBVPs) and (B) adult human brain derived-vascular pericytes (aHBVP) were
seeded in black clear bottomed 96-well plates at 5,000 cells per well and left to
settle overnight. Pericytes were then incubated with recombinant Aβ peptides
(rPeptide, diluted in 35% acetonitrile as a stock and diluted in serum-free medium)
for 24 h. Cell toxicity was assessed using an ethidium dye, in the live/dead
mammalian cell assay (Invitrogen, United Kingdom), according to the
manufacturer’s guidelines (n = 2). The percentage of cells that had died was
calculated with reference to the untreated control wells. The bars represent the
mean values and SD.
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